Automated Breast Ultrasound With Computer Aided Detection
Dedicated computer aided detection (CAD)-software for automated breast ultrasound has the potential to improve the cancer detection rates of radiologists screening for breast cancer, according to new research published in the European Journal of Radiology.
Mammography surveillance programmes have shown to reduce deaths from breast cancer. However, the sensitivity of mammography is suboptimal, and decreases in women with “dense breasts”. Breast ultrasound is increasingly being used as an adjunct to mammographic screening. Handheld ultrasound (HHUS) and automated 3D breast ultrasound systems (ABUS) have been reported to increase the cancer detection rate as a supplement to mammographic screening in women with dense breasts.
ABUS is primarily developed for screening. However, for a full coverage of both breasts ABUS consists of two to five acquisitions per breast. Each acquisition contains over 300 transverse images and reconstructions in coronal and sagittal planes. Consequently, the large size of the ABUS volumes might cause oversight errors in some malignancies. Accurate CAD-software may help to detect cancers in ABUS datasets and might improve efficiency in the workflow of radiologists. However, the optimal method of implementing CAD-software in the reading process is unknown.
In this study, researchers compared the diagnostic accuracy of radiologists screening ABUS scans for breast cancer with and without CAD-software support. Ninety ABUS views of 90 patients were randomly selected from a multicentre archive; this dataset included normal cases (n = 40) with >1 year of follow-up, benign (n = 30) lesions that were either biopsied or remained stable, and malignant lesions (n = 20). Six readers evaluated all cases with and without CAD in two sessions.
Results showed that, without CAD, the average area-under-the-curve (AUC) of the readers was 0.77 and significantly improved with CAD to 0.84 (p = 0.001). Sensitivity of all readers improved (range 5.2–10.6%) by using CAD but specificity decreased in four out of six readers (range 1.4–5.7%). No significant difference was observed in the AUC between experienced radiologists and residents both with and without CAD.
Commercially available CAD-software, such as the one used in this study, includes conventional CAD-marks and an intelligent minimum intensity projection of the breast tissue.
"CAD can help to avoid oversight errors by radiologists, if the CAD-software does detect the cancer and the radiologist does not ignore the CAD result. Moreover, by marking lesions as being suspicious the frequency of interpretation errors might be reduced," the authors write. "However, too many CAD marks might result in a diminishing confidence of readers in the CAD system, and hence a failure of the CAD system to improve reader performance. In this study we adjusted the average number of marks to one per view. This appeared to be an acceptable setting for the readers."
Source: European Journal of Radiology
Image Credit: Lee Health
Published on : Tue, 20 Jun 2017
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes...
The SonoSite SII features a new touchscreen user interface with a clinician-driven menu logic that adaptively adjusts to your imaging needs – “what you need, is what you see”. An embedded dual transducer connector allows you to quickly switch between...
Transform the breast imaging patient experience The SmartCurve system provides a curved compression surface that offers a more comfortable patient experience without compromising image quality, exam time, dose or workflow.1 The SmartCurve system is...
The enlightened choice for high-field MRI ECHELON Smart is Hitachi’s smart MRI concept which combines ‘SmartQUALITY’ for superb clinical images and sophisticated applications, ‘SmartSPEED’ for reduced examination time, ‘SmartCOMFORT’ for an extraordinary...
Better detection. Clinically superior. Low dose.** What if we could find breast cancers earlier? See lesions more clearly? Reduce the number of unnecessary biopsies? Questions like these inspired Hologic researchers and scientists to develop Hologic...